Cullinan Therapeutics

IPO

Science That Moves

Public · Cambridge, United States

Employees
51–200
Business Model
B2B
Type
Public

About

Biopharmaceutical company developing first- or best-in-class therapies for autoimmune diseases and cancer.

Summary

Cullinan Therapeutics is a Biotech company based in Cambridge, United States.

Tech & App Stack

3 technologies & apps tracked

Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Secondary MarketSecondary MarketJan 2024
$280.0M

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Similar Companies